MAPT and Alzheimer disease: While multiple tau kinases including GSK3β, CDK5, or casein kinase 2 and tau itself have been reported to contribute to axonal degeneration in AD especially through axonal transport deficit [12], no kinase except TTBK1 is specifically expressed in the EC and PP where early AD pathology evolves.